Recursion
Recursion uses artificial intelligence to speed up drug discovery, and its reliance on heavy computing power places it among third-order compute beneficiaries, one step removed from chip makers.
Checked against the company's own business description in its latest annual filing.
Latest disclosed
10-Q filed 2026-08-05 · period ending 2026-06-30
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.